KevinRBoothMD

Neurology • Collegeville, PA

Sleep Medicine, Neurodegenerative

Director/Clinical Scientist Global Product Development Pfizer

Join to view full profile

Dr. Booth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Booth's full profile

Already have an account?

Office
500 Arcola Rd.
F-3231
Collegeville, PA 19426
Is this information wrong?

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1986 - 1989
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1985 - 1986
University of Michigan Medical SchoolClass of 1985

Certifications & Licensure

PA State Medical License 2016 - 2024
American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

36 citations
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
Michael Hüll, Carl H. Sadowsky, Heii Arai, Ghislaine Le Prince Leterme, Ann R Holstein, Kevin Booth, Yahong Peng, Tamotsu Yoshiyama, Hideo Suzuki, Nzeera Ketter, Enchi...> ;Current Alzheimer Research. 2017 Jun 30
24 citations
Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies.
Adrian Ivanoiu, Jérémie Pariente, Kevin Booth, Kasia Lobello, Gerald Luscan, Lisa Hua, Prisca Lucas, Scot Styren, Lingfeng Yang, David Li, Ronald Black, H. Robert Bras...> ;Alzheimer's Research & Therapy. 2016 Jun 23
188 citations
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials.
Rik Vandenberghe, Juha O. Rinne, Mercè Boada, Sadao Katayama, Philip Scheltens, Bruno Vellas, Michael Tuchman, Achim Gass, Jochen B. Fiebach, Derek L. G. Hill, Kasia L...> ;Alzheimer's Research & Therapy. 2016 May 12
22 citations
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to...
Mark Brody, Enchi Liu, Jianing Di, Ming Lu, Richard Margolin, John L. Werth, Kevin Booth, Anna Shadman, H. Robert Brashear, Gerald Novak> ;Journal of Alzheimer's Disease. 2016 Jan 1
110 citations
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Enchi Liu, Mark E. Schmidt, Richard Margolin, Reisa Sperling, Robert A. Koeppe, Neale S. Mason, William E. Klunk, Chester A. Mathis, Stephen Salloway, Nicholas C. Fox,...> ;Neurology. 2015 Aug 25
Motor evoked potentials and central motor conduction: studies of transcranial magnetic stimulation with recording from the leg.
Booth KR, Streletz LJ, Raab VE, Kerrigan JJ, Alaimo MA, Herbison GJ> ;Electroencephalogr Clin Neurophysiol. 1991-02-01
Join now to see all

Industry Relationships

Director, Pfizer, Inc.Clinical Development clinician in neuropsychiatric and immunologic diseasesDisclosure: Employee of Pfizer, Inc.2005 - Present